WallStreetZenWallStreetZen

NYSE: DDS
Dillard's Inc Stock Forecast, Predictions & Price Target

Analyst price target for DDS

Based on 2 analysts offering 12 month price targets for Dillard's Inc.
Min Forecast
$190.00-53.38%
Avg Forecast
$260.00-36.2%
Max Forecast
$330.00-19.02%

Should I buy or sell DDS stock?

Based on 2 analysts offering ratings for Dillard's Inc.
Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
1 analysts 50%

Be the first to know when Wall Street analysts revise their DDS stock forecasts and price targets.

DDS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-27
lockedlocked$00.00+00.00%2023-11-10

1 of 1

Forecast return on equity

Is DDS forecast to generate an efficient return?

Forecast return on assets

Is DDS forecast to generate an efficient return on assets?

DDS revenue forecast

What is DDS's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$6.6B-3.58%
Avg 2 year Forecast
$6.7B-2.04%
Avg 3 year Forecast
$6.8B-1.12%
DDS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DDS revenue growth forecast

How is DDS forecast to perform vs Department Stores companies and vs the US market?
Company
-0.3%
Industry
-0.84%
Market
10.27%
DDS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DDS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DDS vs Department Store Stocks

TickerPricePrice TargetUp/downsideConsensus
DDS$407.52$260.00-36.20%Sell
M$19.01$19.86+4.46%Buy
JWN$17.95$16.82-6.31%Sell
KSS$21.86$23.86+9.14%Sell
CBD$0.46N/AN/A

Dillard's Stock Forecast FAQ

Is Dillard's Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: DDS) stock is to Sell DDS stock.

Out of 2 analysts, 0 (0%) are recommending DDS as a Strong Buy, 0 (0%) are recommending DDS as a Buy, 1 (50%) are recommending DDS as a Hold, 0 (0%) are recommending DDS as a Sell, and 1 (50%) are recommending DDS as a Strong Sell.

If you're new to stock investing, here's how to buy Dillard's stock.

What is DDS's revenue growth forecast for 2025-2027?

(NYSE: DDS) Dillard's's forecast annual revenue growth rate of -0.3% is forecast to beat the US Department Stores industry's average forecast revenue growth rate of -0.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Dillard's's revenue in 2024 is $6,874,420,000.On average, 3 Wall Street analysts forecast DDS's revenue for 2025 to be $107,572,794,683, with the lowest DDS revenue forecast at $104,830,073,802, and the highest DDS revenue forecast at $109,601,229,832. On average, 3 Wall Street analysts forecast DDS's revenue for 2026 to be $109,292,257,837, with the lowest DDS revenue forecast at $107,651,997,464, and the highest DDS revenue forecast at $110,234,689,776.

In 2027, DDS is forecast to generate $110,324,442,107 in revenue, with the lowest revenue forecast at $110,324,442,107 and the highest revenue forecast at $110,324,442,107.

What is DDS's forecast return on assets (ROA) for 2025-2027?

(NYSE: DDS) forecast ROA is N/A, which is lower than the forecast US Department Stores industry average of N/A.

What is DDS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year DDS price target, the average DDS price target is $260.00, with the highest DDS stock price forecast at $330.00 and the lowest DDS stock price forecast at $190.00.

On average, Wall Street analysts predict that Dillard's's share price could fall to $260.00 by Feb 27, 2025. The average Dillard's stock price prediction forecasts a potential downside of 36.2% from the current DDS share price of $407.52.

What is DDS's forecast return on equity (ROE) for 2025-2027?

(NYSE: DDS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.